Open Access 09.06.2020 | COVID-19 | Letter
Efficacy and safety of Anluohuaxian in the treatment of patients with severe Coronavirus disease 2019- a multicenter, open label, randomized controlled study: a structured summary of a study protocol for a randomised controlled trial
Erschienen in: Trials | Ausgabe 1/2020